June 5, 2012
RaQualia Pharma, Inc. announced on June 1 the initiation of a PI study in the UK for RQ-00000010 (development code), a 5-HT 4 partial agonist that is developed for GI diseases. Discovered by RaQualia, RQ-00000010 has high activity and selectivity...read more